For the year ending 2025-12-31, CUE has $42,212K in assets. $15,780K in debts. $27,136K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 27,136 | |||
| Accounts receivable | 5,546 | |||
| Deposits, current portion | 1,093 | |||
| Prepaid expenses and other current assets | 1,309 | |||
| Foreign withholding tax receivable | 1,899 | |||
| Total current assets | 36,983 | |||
| Total property and equipment | 3,904 | |||
| Less accumulated depreciation | 3,663 | |||
| Property and equipment, net | 241 | |||
| Operating lease, right-of-use asset | 4,074 | |||
| Deposits, net of current portion | 666 | |||
| Restricted cash | 154 | |||
| Other long term assets | 94 | |||
| Total assets | 42,212 | |||
| Accounts payable | 3,948 | |||
| Accrued expenses | 1,611 | |||
| Research and development contract liability, current portion | 5,335 | |||
| Operating lease liabilities, net of current portion | 1,911 | |||
| Current portion of long-term debt, net | 0 | |||
| Other current payable | 689 | |||
| Total current liabilities | 13,494 | |||
| Operating lease liabilities, current portion | 2,286 | |||
| Total liabilities | 15,780 | |||
| Common stock, 0.001 par value 300,000,000 and 200,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 96,621,218 and 61,819,101 shares issued and outstanding at december 31, 2025 and 2024, respectively | 97 | |||
| Additional paid in capital | 394,801 | |||
| Accumulated deficit | -368,466 | |||
| Total stockholders equity | 26,432 | |||
| Total liabilities and stockholders equity | 42,212 | |||
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)